Clinical Trial Update: Efficacy of Bevacizumab Monotherapy in Treatment of Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing bevacizumab as a monotherapy for metastatic melanoma has completed and reported efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Haukeland University Hospital | Conditions: Metastatic Melanoma | Phase 2 | Status: COMPLETED